Lea Eslava-Kim, PharmD

Most Recent Articles by Lea Eslava-Kim, PharmD

FDA to Review Drug for Exertional Heat Stroke

By Jan 23, 2017

Eagle announced the complete submission to the Food and Drug Administration (FDA) of its New Drug Application (NDA) for Ryanodex for the treatment of exertional heat stroke (EHS).

FDA Grants Deuterated CF Therapy Orphan Drug Designation

By Jan 20, 2017

The Food and Drug Administration (FDA) has granted Orphan Drug designation for Concert Pharmaceuticals' CTP-656 (deuterated ivacaftor) for the treatment of cystic fibrosis.

FDA to Review Potential Single-Dose Therapy for Bacterial Vaginosis

By Jan 19, 2017

Symbiomix announced the submission of a New Drug Application (NDA) to the Food and Drug Administration (FDA) for Solosec (secnidazole oral granules) for the treatment of bacterial vaginosis (BV).

Oral Therapy for Uterine Fibroids Demonstrates Efficacy in Study

By Jan 17, 2017

Allergan and Gedeon Richter announced positive results from the second Phase 3 trial of ulipristal acetate, evaluating its efficacy and safety for the treatment of abnormal bleeding due to uterine fibroids in women.

Novel Cephalosporin Demonstrates Superiority in Complicated UTI

By Jan 13, 2017

Shionogi has announced positive results from the APEKs-cUTI* study which evaluated their novel antibiotic, cefiderocol (S-649266), for the treatment of patients with serious complicated urinary tract infection (cUTI) by Gram-negative bacteria.

More Articles by Lea Eslava-Kim, PharmD